Press release
United States Diffuse Large B-cell Lymphoma Therapeutics Market Set to Reach USD 7.2 Billion by 2031 | DataM Intelligence
Diffuse Large B-cell Lymphoma Therapeutics Market
Diffuse Large B-cell Lymphoma (DLBCL) therapeutics target one of the most common and aggressive types of non-Hodgkin lymphoma. Standard treatment involves R-CHOP chemotherapy, combining immunotherapy and cytotoxic agents. New approaches include CAR-T cell therapy, monoclonal antibodies, and targeted small molecules. Personalized treatment is guided by molecular subtyping and genetic profiling. Relapsed cases benefit from stem cell transplantation or novel immunotherapies. Research continues to enhance survival rates and minimize treatment-related toxicity.
📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Diffuse Large B-cell Lymphoma Therapeutics Market Landscape:- https://datamintelligence.com/download-sample/diffuse-large-b-cell-lymphoma-therapeutics-market?Ranjith
☛ Diffuse Large B-cell Lymphoma Therapeutics Market Recent Developments 2025:
United States: Recent Industry Developments
✅ In July 2025, Gilead Sciences announced positive Phase 3 results for CAR-T cell therapy Yescarta in relapsed/refractory DLBCL patients, showing improved overall response and durable remission.
✅ In June 2025, Roche/Genentech expanded the use of Gazyva (obinutuzumab) in combination with chemotherapy for first-line DLBCL treatment, demonstrating enhanced progression-free survival.
✅ In May 2025, Bristol Myers Squibb initiated clinical trials for a bispecific antibody therapy targeting CD20 and CD3, aiming to enhance immune-mediated tumor cell killing in DLBCL.
Japan: Recent Industry Developments
✅ In July 2025, Astellas Pharma advanced novel targeted kinase inhibitors for DLBCL, focusing on patients with high-risk molecular subtypes resistant to standard therapy.
✅ In June 2025, Chugai Pharmaceutical initiated research on ADC (antibody-drug conjugate) therapies for relapsed DLBCL, combining targeted delivery with potent cytotoxic agents.
✅ In May 2025, Takeda Pharmaceutical partnered with Japanese cancer centers to develop personalized immunotherapy protocols using next-generation sequencing for patient stratification in DLBCL treatment.
☛ Diffuse Large B-cell Lymphoma Therapeutics Market Competitive Landscape:
F. Hoffmann-La Roche Ltd, Novartis AG, Celltrion, Karyopharm Therapeutics, Kite Pharma, MorphoSys AG, AbbVie, CTI BioPharma, Seagen Inc., TG Therapeutics.
Research Methodology
We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.
📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/diffuse-large-b-cell-lymphoma-therapeutics-market?Ranjith
☛ Segments Covered in the Diffuse Large B-cell Lymphoma Therapeutics Market:
By Drug Type: Immuno and Targeted Drugs | Others (Combination Drugs)
By Route of Administration: Intravenous Route | Oral
By End User: Hospitals | Cancer Centers | Others
☛ This Report Includes:
✔ Comprehensive go-to-market strategies with actionable insights.
✔ Unbiased evaluation of overall market performance.
✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.
✔ Tailored regional and country-level reports with detailed localized analysis available on request.
✔ Identification of niche segments and high-growth regions presenting strong opportunities.
✔ Accurate regional forecasts using both top-down and bottom-up approaches.
📌 Get Corporate Access to Live Diffuse Large B-cell Lymphoma Therapeutics Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=diffuse-large-b-cell-lymphoma-therapeutics-market?Ranjith
☛ Regional Analysis for Diffuse Large B-cell Lymphoma Therapeutics Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription
☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Diffuse Large B-cell Lymphoma Therapeutics Market Set to Reach USD 7.2 Billion by 2031 | DataM Intelligence here
News-ID: 4223563 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Child Resistant Packaging Market Grows at 5.4% CAGR as Stringent Safety Regulati …
The Child Resistant Packaging Market is estimated to reach at a CAGR of 5.4% from 2024 to 2031.This robust growth is driven by stringent government regulations mandating child safety in pharmaceuticals, household chemicals, and cannabis products, rising incidents of accidental child poisoning, increasing demand for sustainable and recyclable packaging solutions, advancements in innovative designs like push-and-turn closures and blister packs, expanding pharmaceutical and cannabis industries, and growing consumer awareness…
North America Leads Traveler's Diarrhea Market Growth Driven by High Outbound Tr …
The Traveler's Diarrhea Market was valued at USD 699 million in 2024 and is projected to reach USD 1.29 billion by 2034, growing at a CAGR of 6.3% from 2025 to 2034. This robust growth is driven by the increasing volume of international travel and tourism, rising prevalence of foodborne infections and bacterial pathogens like E. coli, growing awareness of preventive measures and over-the-counter treatments, demand for effective antibiotics…
Digital Out of Home (DOOH) Advertising Market Expands at 13.5% CAGR as AI, Progr …
The Digital Out of Home (DOOH) Advertising Market is growing at a CAGR of 13.5% from 2024 to 2031. This robust growth is driven by the shift toward dynamic, interactive, and data-driven advertising over static formats, advancements in technologies like AI, IoT, programmatic buying, and real-time content optimization, rising urbanization and infrastructure development increasing audience exposure, integration with mobile/social media for omnichannel engagement, demand for targeted and measurable campaigns, and…
U.S. Lung Cancer Surgery Market Grows as Robotic & Minimally Invasive Techniques …
Leander, Texas, United States - Dec.17.2025
As per DataM Intelligence research report "Global Lung Cancer Surgery Market is growing with a high 3.6 % CAGR from 2024 to 2031."Growing prevalence of lung cancer, rising air pollution, increasing smoking rates, and advancements in minimally invasive and robotic-assisted surgical techniques are driving the lung cancer surgery market.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/lung-cancer-surgery-market?sindhuri
Lung Cancer Surgery Market: Recent Industry…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
